Literature DB >> 6216262

Monocyte-dependent serum suppression of lymphocyte blastogenesis in Hodgkin's disease: an association with nephrotic syndrome.

J P Crowley, H J Ree, A Esparza.   

Abstract

A factor inhibitory to PHA-induced lymphocyte blastogenesis was found to be present in the serum of a patient with advanced Hodgkin's disease and nephrotic syndrome. The inhibitory activity for both syngeneic and allogeneic lymphocytes was dependent on the presence of peripheral blood monocytes. The Raji-cell serum assay, as well as immunofluorescence and light and electron microscopy of the renal biopsy, showed no evidence of immune complexes. Nevertheless, a high serum IgE level as well as the finding that ultracentrifugation and heating at 56 degrees C significantly reduced the inhibitory activity (P less than 0.01) suggested the possibility that an immune complex might have mediated the suppressive activity. Treatment of the Hodgkin's disease with combined chemotherapy caused a marked reduction in the monocyte-dependent serum inhibitory activity which in turn coincided with a prompt remission of the nephrotic syndrome and marked regression of disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6216262     DOI: 10.1007/bf00915066

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  17 in total

1.  Nephrotic syndrome in Hodgkin's disease. Evidence for pathogenesis alternative to immune complex deposition.

Authors:  A V Moorthy; S W Zimmerman; P M Burkholder
Journal:  Am J Med       Date:  1976-10       Impact factor: 4.965

2.  Glomerular lesions in Hodgkin disease.

Authors:  M N Yum; J L Edwards; S Kleit
Journal:  Arch Pathol       Date:  1975-12

Review 3.  Glomerulopathies of neoplasia.

Authors:  J W Eagen
Journal:  Kidney Int       Date:  1977-05       Impact factor: 10.612

4.  Hodgkin's disease complicated by the nephrotic syndrome.

Authors:  R C Routledge; I M Hann; P H Jones
Journal:  Cancer       Date:  1976-10       Impact factor: 6.860

5.  Prostaglandin-producing suppressor cells in Hodgkin's disease.

Authors:  J S Goodwin; R P Messner; A D Bankhurst; G T Peake; J H Saiki; R C Williams
Journal:  N Engl J Med       Date:  1977-11-03       Impact factor: 91.245

6.  Increased sensitivity to normal adherent suppressor cells in untreated advanced Hodgkin's disease.

Authors:  R I Fisher; C Vanhaelen; F Bostick
Journal:  Blood       Date:  1981-05       Impact factor: 22.113

7.  Circulating immune complexes in Hodgkin's disease.

Authors:  C A Brown; C L Hall; J C Long; K Carey; S A Weitzman; A C Aisenberg
Journal:  Am J Med       Date:  1978-02       Impact factor: 4.965

8.  Hodgkin's disease. An immunodepleting and immunosuppressive disorder.

Authors:  J J Twomey; A H Laughter; S Farrow; C C Douglass
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

9.  Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.

Authors:  S M Hillinger; G P Herzig
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

10.  Multivariate analysis of T-cell functional defects and circulating serum factors in Hodgkin's disease.

Authors:  R S Schulof; R S Bockman; J A Garofalo; C Cirrincione; S Cunningham-Rundles; G Fernandes; N K Day; C M Pinsky; G S Incefy; H T Thaler; R A Good; S Gupta
Journal:  Cancer       Date:  1981-08-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.